Introduktion
Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Ernest Mario. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.
Gennemsnitlig handelsrentabilitet
Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.
Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.
Opdateringsfrekvens: Dagligt
Virksomheder med rapporterede insider-stillinger
SEC-registreringen viser, at Ernest Mario har rapporteret besiddelser eller handler i følgende virksomheder:
Sikkerhed | Titel | Senest indberettede beholdninger |
---|---|---|
US:SLNO / Soleno Therapeutics, Inc. | Director | 193.066 |
US:EYEN / Eyenovia, Inc. | Director | 9.653 |
Director | 49.000 | |
US:CELG / Celgene Corp. | Director | 0 |
US:TNXP / Tonix Pharmaceuticals Holding Corp. | Director | 50.000 |
US:CMRX / Chimerix, Inc. | Director | 108.167 |
US:BSX / Boston Scientific Corporation | Director | 86.032 |
US:XNPT / XenoPort, Inc. | Director | 0 |
US:928551AA8 / VIVUS, Inc. Bond | Director | 81.125 |
US:MAXY / Maxygen Inc | Director | 62.964 |
Sådan fortolkes diagrammerne
Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Ernest Mario. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.
I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.
Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.
Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.
Insiderkøb HYPD / Hyperion DeFi, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HYPD / Hyperion DeFi, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg HYPD / Hyperion DeFi, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HYPD / Hyperion DeFi, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderkøb SLNO / Soleno Therapeutics, Inc. – kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HYPD / Hyperion DeFi, Inc.. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insidersalg SLNO / Soleno Therapeutics, Inc. – kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HYPD / Hyperion DeFi, Inc.. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Handelsdato | Ticker | Insider | Rapporteret Aktier |
Rapporteret Pris |
Justeret Aktier |
Justeret Pris |
Omkostningsgrundlag | dage til Min |
Pris kl Min |
Max tab Undgået ($) |
Max tab Undgået (%) |
---|---|---|---|---|---|---|---|
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination |
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Insiderhandelshistorie
Denne tabel viser den komplette liste over insiderhandler foretaget af Ernest Mario som oplyst til Securities Exchange Commission (SEC).
Fil dato | Transdato | Form | Ticker | Sikkerhed | Kode | Aktier | Resterende aktier | Procent Lave om |
Del Pris |
Tran Værdi |
Tilbage Værdi |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2024-06-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 6.500 | 193.066 | 3,48 | ||||
2024-05-23 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
X - Other | 62.000 | 186.566 | 49,77 | 4,50 | 279.000 | 839.547 | |
2024-01-10 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -3.523 | 124.566 | -2,75 | ||||
2023-12-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
G - Gift | -8.700 | 128.089 | -6,36 | ||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930.000 | 930.000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Warrant (right to buy) |
P - Purchase | 930.000 | 930.000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930.000 | 930.000 | |||||
2022-04-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
P - Purchase | 930.000 | 930.000 | |||||
2022-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 56.338 | 1.433.135 | 4,09 | 0,36 | 20.000 | 508.763 | |
2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9.653 | 9.653 | |||||
2021-11-22 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 6.963 | 382.706 | 1,85 | ||||
2021-11-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 26.888 | 1.376.797 | 1,99 | ||||
2021-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 21.978 | 1.349.909 | 1,66 | 0,91 | 20.000 | 1.228.417 | |
2021-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 31.862 | 31.862 | |||||
2021-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 16.529 | 1.176.416 | 1,43 | 1,21 | 20.000 | 1.423.463 | |
2021-02-02 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8.928 | 1.157.804 | 0,78 | ||||
2021-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49.000 | 49.000 | |||||
2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
X - Other | -41.216 | 0 | -100,00 | ||||
2021-01-19 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
X - Other | 41.216 | 375.743 | 12,32 | 2,27 | 93.560 | 852.937 | |
2021-01-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 40.000 | 40.000 | |||||
2020-11-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10.057 | 1.148.876 | 0,88 | 1,74 | 17.499 | 1.999.044 | |
2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9.820 | 9.820 | |||||
2020-09-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 7.288 | 334.527 | 2,23 | ||||
2020-08-03 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10.174 | 10.174 | 1,72 | 17.499 | 17.499 | ||
2020-05-20 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 9.530 | 9.530 | |||||
2020-05-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5.738 | 5.738 | 3,05 | 17.501 | 17.501 | ||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class B Warrant |
P - Purchase | 61.823 | 61.823 | |||||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Class A Warrant |
P - Purchase | 41.216 | 41.216 | |||||
2020-03-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 82.431 | 327.239 | 33,67 | 2,27 | 187.118 | 742.833 | |
2020-01-24 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 10.448 | 10.448 | 3,35 | 35.001 | 35.001 | ||
2020-01-22 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49.000 | 49.000 | |||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -4.756 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -970 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
D - Sale to Issuer | -300 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -13.266 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10.500 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -11.000 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -10.000 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
D - Sale to Issuer | -20.700 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -4.908 | 0 | -100,00 | ||||
2019-11-22 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
D - Sale to Issuer | -62.884 | 0 | -100,00 | ||||
2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 9.057 | 9.057 | |||||
2019-08-20 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 8.038 | 280.779 | 2,95 | ||||
2019-07-15 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 35.971 | 272.741 | 15,19 | 2,78 | 99.999 | 758.220 | |
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 0 | -100,00 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 62.884 | 0,60 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 300 | -50,00 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 62.509 | 0,48 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -484 | 970 | -33,29 | ||||
2019-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 484 | 62.209 | 0,78 | ||||
2019-06-12 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 13.000 | 13.000 | |||||
2019-06-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 4.756 | 4.756 | |||||
2019-05-21 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
P - Purchase | 90.000 | 236.770 | 61,32 | 10,00 | 900.000 | 2.367.700 | |
2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | 2.908 | 4.908 | 145,40 | 85,97 | 250.001 | 421.941 | |
2019-03-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
J - Other | -2.908 | 55.005 | -5,02 | 85,97 | -250.001 | 4.728.780 | |
2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 2.000 | 2.000 | 89,99 | 179.980 | 179.980 | ||
2019-02-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -5.100 | 57.913 | -8,09 | ||||
2019-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 49.000 | 49.000 | |||||
2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -8.600 | 0 | -100,00 | ||||
2018-12-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 8.600 | 63.013 | 15,81 | 59,06 | 507.873 | 3.721.233 | |
2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -10.000 | 8.600 | -53,76 | ||||
2018-11-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 10.000 | 54.413 | 22,52 | 59,06 | 590.550 | 3.213.360 | |
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -44.000 | 0 | -100,00 | ||||
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -833 | 0 | -100,00 | ||||
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 44.000 | 169.000 | 35,20 | 3,45 | 151.800 | 583.050 | |
2018-10-31 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 833 | 125.000 | 0,67 | 1,37 | 1.141 | 171.250 | |
2018-08-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12.000 | 44.413 | -21,27 | 92,32 | -1.107.888 | 4.100.386 | |
2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Stock Option (right to buy) |
A - Award | 4.465 | 4.465 | |||||
2018-07-26 |
|
4 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
A - Award | 4.033 | 146.770 | 2,83 | ||||
2018-06-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 16.500 | 50.000 | 49,25 | 4,48 | 73.920 | 224.000 | |
2018-06-26 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 10.000 | 10.000 | |||||
2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -334 | 0 | -100,00 | ||||
2018-06-18 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 334 | 56.413 | 0,60 | ||||
2018-06-18 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Employee stock option (right to buy) |
A - Award | 15.931 | 15.931 | |||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 375 | -50,00 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 56.079 | 0,67 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -300 | 600 | -33,33 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 300 | 55.704 | 0,54 | ||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 13.266 | 13.266 | |||||
2018-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1.454 | 1.454 | |||||
2018-06-13 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20.000 | 20.000 | |||||
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 3.606 | 475.324 | 0,76 | 2,04 | 7.356 | 969.661 | |
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 471.718 | 0,11 | 2,04 | 1.020 | 962.305 | |
2018-06-13 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4.980 | 471.218 | 1,07 | 2,05 | 10.209 | 965.997 | |
2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 14.803 | 466.238 | 3,28 | 2,04 | 30.257 | 952.990 | |
2018-06-11 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 4.611 | 451.435 | 1,03 | 2,00 | 9.234 | 903.999 | |
2018-06-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1.200 | 446.824 | 0,27 | 2,05 | 2.460 | 915.989 | |
2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 1.300 | 445.624 | 0,29 | 2,05 | 2.665 | 913.529 | |
2018-06-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 444.324 | 0,11 | 2,05 | 1.025 | 910.864 | |
2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 500 | 443.824 | 0,11 | 2,01 | 1.005 | 892.086 | |
2018-05-29 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5.000 | 443.324 | 1,14 | 2,05 | 10.250 | 908.814 | |
2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 5.000 | 438.324 | 1,15 | 1,94 | 9.720 | 852.102 | |
2018-05-22 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25.000 | 433.324 | 6,12 | 1,95 | 48.750 | 844.982 | |
2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -15.000 | 108.167 | -12,18 | 4,81 | -72.142 | 520.229 | |
2018-05-21 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30.000 | 123.167 | -19,59 | 4,80 | -143.931 | 590.918 | |
2018-05-21 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 25.000 | 408.324 | 6,52 | 1,90 | 47.500 | 775.816 | |
2018-05-17 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30.000 | 153.167 | -16,38 | 4,79 | -143.808 | 734.221 | |
2018-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -30.000 | 183.167 | -14,07 | 4,69 | -140.808 | 859.713 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22.553 | 213.167 | -9,57 | 4,67 | -105.232 | 994.637 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -22.857 | 235.720 | -8,84 | 4,63 | -105.766 | 1.090.747 | |
2018-05-15 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -7.143 | 258.577 | -2,69 | 4,57 | -32.614 | 1.180.637 | |
2018-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -2.815 | 265.720 | -1,05 | 4,60 | -12.949 | 1.222.312 | |
2018-04-24 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (Right to Buy) |
A - Award | 44.603 | 44.603 | |||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248.334 | ||||||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248.334 | ||||||||
2018-04-11 | 3 | KIN |
Kindred Biosciences, Inc.
Common Stock |
248.334 | ||||||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | 10.000 | 33.500 | 42,55 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
G - Gift | -10.000 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 64.572 | 1,18 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -750 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 750 | 63.822 | 1,19 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Units |
M - Exercise | -600 | 0 | -100,00 | ||||
2018-03-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
M - Exercise | 600 | 26.648 | 2,30 | ||||
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13.370 | 55.404 | -19,44 | 94,49 | -1.263.298 | 5.234.985 | |
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.250 | 324 | -87,41 | ||||
2018-02-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.250 | 324 | -87,41 | ||||
2018-02-07 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 8.689 | 704.352 | 1,25 | 1,73 | 15.000 | 1.215.923 | |
2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285.474 | ||||||||
2018-01-24 | 3 | EYEN |
EYENOVIA, INC.
Common Stock, par value $.0001 |
285.474 | ||||||||
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5.000 | 23.500 | -17,54 | 3,46 | -17.300 | 81.310 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -8.965 | 28.500 | -23,93 | 3,44 | -30.840 | 98.040 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6.035 | 37.465 | -13,87 | 3,51 | -21.183 | 131.502 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -10.000 | 43.500 | -18,69 | 3,57 | -35.700 | 155.295 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -5.000 | 53.500 | -8,55 | 3,55 | -17.750 | 189.925 | |
2017-12-22 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -1.967 | 55.467 | -3,42 | 3,58 | -7.042 | 198.572 | |
2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -13.600 | 0 | -100,00 | ||||
2017-11-01 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 13.600 | 71.024 | 23,68 | 31,80 | 432.412 | 2.258.208 | |
2017-10-04 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 28.846 | 1.873.174 | 1,56 | 0,52 | 15.000 | 974.050 | |
2017-08-31 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -12.000 | 57.424 | -17,29 | 121,24 | -1.454.880 | 6.962.086 | |
2017-08-14 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -18.506 | 69.424 | -21,05 | 130,52 | -2.415.403 | 9.061.220 | |
2017-07-17 |
|
4 | SLNO |
SOLENO THERAPEUTICS INC
Common Stock |
A - Award | 24.590 | 1.844.328 | 1,35 | 0,61 | 15.000 | 1.125.040 | |
2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -734 | 0 | -100,00 | ||||
2017-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 734 | 87.930 | 0,84 | ||||
2017-06-30 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
S - Sale | -6.105 | 5.895 | -50,88 | 4,28 | -26.117 | 25.219 | |
2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 6.341 | 6.341 | |||||
2017-06-29 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 21.000 | 21.000 | |||||
2017-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 20.000 | 20.000 | |||||
2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 334 | -49,93 | ||||
2017-06-20 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 87.196 | 0,38 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -375 | 750 | -33,33 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 375 | 86.863 | 0,43 | ||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 900 | 900 | |||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10.500 | 10.500 | |||||
2017-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -3.570 | 86.488 | -3,96 | ||||
2017-05-09 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 45.139 | 45.139 | |||||
2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 23.809 | 1.819.738 | 1,33 | 0,63 | 15.000 | 1.146.435 | |
2017-04-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 16.667 | 1.795.929 | 0,94 | 0,90 | 15.000 | 1.616.336 | |
2017-01-31 |
|
5 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -4.125 | 90.058 | -4,38 | ||||
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -20.291 | 268.535 | -7,03 | 4,52 | -91.634 | 1.212.704 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -4.000 | 288.826 | -1,37 | 4,67 | -18.683 | 1.349.020 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | -3.636 | 292.826 | -1,23 | 4,65 | -16.907 | 1.361.641 | |
2016-12-29 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
S - Sale | X | -72.073 | 296.462 | -19,56 | 4,68 | -337.143 | 1.386.790 |
2016-11-28 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 120.000 | 120.000 | 0,40 | 48.600 | 48.600 | ||
2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock Purchase Warrant |
P - Purchase | 100.000 | 100.000 | |||||
2016-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100.000 | 630.724 | 18,84 | ||||
2016-10-11 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
A - Award | 15.625 | 1.779.262 | 0,89 | ||||
2016-09-26 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -15.000 | 90.058 | -14,28 | 109,42 | -1.641.300 | 9.854.146 | |
2016-09-14 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 100.000 | 530.724 | 23,22 | 0,79 | 79.180 | 420.227 | |
2016-08-19 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 25.000 | 1.763.637 | 1,44 | 0,99 | 24.750 | 1.746.001 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5.637 | 1.688.637 | 0,33 | 1,20 | 6.764 | 2.026.364 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43.169 | 1.683.000 | 2,63 | 1,18 | 50.875 | 1.983.416 | |
2016-08-19 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.738.637 | 2,96 | 1,24 | 62.000 | 2.155.910 | |
2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 734 | -49,97 | ||||
2016-07-05 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 105.058 | 0,70 | ||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.634 | 9.634 | |||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.000 | 9.000 | |||||
2016-06-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 50.000 | 381.440 | 15,09 | 3,70 | 184.845 | 1.410.146 | |
2016-06-21 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 50.000 | 430.724 | 13,13 | 2,00 | 100.000 | 861.448 | |
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -333 | 667 | -33,30 | ||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 333 | 104.325 | 0,32 | ||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1.125 | 1.125 | |||||
2016-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 11.000 | 11.000 | |||||
2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.068 | 0 | -100,00 | ||||
2016-06-13 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.068 | 103.992 | 2,03 | ||||
2016-06-10 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
A - Award | 27.083 | 27.083 | |||||
2016-06-09 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.918.637 | 2,68 | 1,24 | 62.000 | 2.379.110 | |
2016-05-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7.500 | 7.500 | |||||
2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 5.637 | 1.868.637 | 0,30 | 1,20 | 6.764 | 2.242.364 | |
2016-05-23 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 43.169 | 1.863.000 | 2,37 | 1,18 | 50.875 | 2.195.546 | |
2016-05-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 331.440 | 3,11 | 4,53 | 45.328 | 1.502.351 | |
2016-05-12 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 31.042 | 380.724 | 8,88 | 2,30 | 71.356 | 875.170 | |
2016-05-11 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 8.210 | 349.682 | 2,40 | 2,24 | 18.399 | 783.672 | |
2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 24.200 | 321.440 | 8,14 | 4,85 | 117.365 | 1.558.920 | |
2016-05-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 800 | 297.240 | 0,27 | 4,76 | 3.804 | 1.413.376 | |
2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 15.845 | -10,00 | ||||
2016-05-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 296.440 | 0,60 | 5,05 | 8.893 | 1.497.022 | |
2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5.000 | 13.600 | -26,88 | ||||
2016-04-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5.000 | 101.924 | 5,16 | 31,80 | 158.975 | 3.240.674 | |
2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 17.606 | -9,09 | ||||
2016-04-05 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 294.679 | 0,60 | 5,05 | 8.888 | 1.488.129 | |
2016-03-17 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 30.000 | 99.583 | 43,11 | 3,55 | 106.500 | 353.520 | |
2016-03-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 75.000 | 341.472 | 28,15 | 2,29 | 171.712 | 781.800 | |
2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5.000 | 292.919 | 1,74 | 4,78 | 23.898 | 1.400.036 | |
2016-03-16 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 20.000 | 287.919 | 7,46 | 5,13 | 102.628 | 1.477.428 | |
2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 19.366 | -8,34 | ||||
2016-03-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 267.919 | 0,66 | 5,05 | 8.893 | 1.352.991 | |
2016-02-10 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 7.500 | 7.500 | |||||
2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 21.127 | -7,69 | ||||
2016-02-09 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 266.158 | 0,67 | 5,05 | 8.888 | 1.344.098 | |
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -18.600 | 0 | -100,00 | ||||
2016-02-02 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 18.600 | 101.049 | 22,56 | 29,00 | 539.400 | 2.930.421 | |
2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 22.887 | -7,14 | ||||
2016-01-14 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 264.398 | 0,67 | 5,05 | 8.893 | 1.335.210 | |
2016-01-12 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44.000 | 44.000 | |||||
2015-12-30 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 125.000 | 262.637 | 90,82 | 7,09 | 886.612 | 1.862.858 | |
2015-12-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -40.000 | 82.449 | -32,67 | 119,36 | -4.774.400 | 9.841.113 | |
2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 24.648 | -6,66 | ||||
2015-12-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 137.637 | 1,30 | 5,05 | 8.888 | 695.067 | |
2015-11-18 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.639.831 | 3,14 | 1,77 | 88.500 | 2.902.501 | |
2015-11-17 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -125.000 | 86.032 | -59,23 | 17,63 | -2.203.162 | 1.516.340 | |
2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 26.408 | -6,25 | ||||
2015-11-10 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 135.877 | 1,31 | 5,05 | 8.893 | 686.179 | |
2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 28.169 | -5,88 | ||||
2015-10-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 134.116 | 1,33 | 5,05 | 8.893 | 677.286 | |
2015-09-14 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 15.000 | 1.589.831 | 0,95 | 2,28 | 34.200 | 3.624.815 | |
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 8.319 | -9,09 | ||||
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.760 | 29.930 | -5,55 | ||||
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 132.355 | 0,63 | 45,15 | 37.565 | 5.975.828 | |
2015-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.760 | 131.523 | 1,36 | 5,05 | 8.888 | 664.191 | |
2015-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 10.000 | 260.472 | 3,99 | 6,05 | 60.500 | 1.575.856 | |
2015-08-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 1.468 | 250.472 | 0,59 | 6,40 | 9.395 | 1.603.021 | |
2015-08-25 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 16.228 | 1.553.999 | 1,06 | 1,91 | 30.995 | 2.968.138 | |
2015-08-25 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 2.532 | 249.004 | 1,03 | 6,20 | 15.698 | 1.543.825 | |
2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -50.000 | 0 | -100,00 | ||||
2015-08-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210.251 | 1.477.771 | 16,59 | ||||
2015-08-20 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 6.000 | 246.472 | 2,50 | 6,64 | 39.867 | 1.637.683 | |
2015-08-20 |
|
4/A | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 210.251 | 1.537.771 | 15,84 | ||||
2015-08-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 15.000 | 240.472 | 6,65 | 6,93 | 104.018 | 1.667.553 | |
2015-08-13 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 10.000 | 1.327.520 | 0,76 | 1,64 | 16.440 | 2.182.443 | |
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Warrant (right to buy) |
J - Other | -205.188 | 0 | -100,00 | ||||
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 50.000 | 1.317.520 | 3,94 | 1,77 | 88.500 | 2.332.010 | |
2015-08-12 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
J - Other | 786.645 | 1.267.520 | 163,59 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -832 | 9.151 | -8,33 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -129 | 0 | -100,00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 0 | -100,00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 31.690 | -10,00 | ||||
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 832 | 129.763 | 0,65 | 45,15 | 37.565 | 5.858.799 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 129 | 128.931 | 0,10 | 23,26 | 3.001 | 2.998.935 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 128.802 | 0,59 | 23,26 | 17.445 | 2.995.935 | |
2015-08-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 128.052 | 2,83 | 5,05 | 17.781 | 646.663 | |
2015-08-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -19.442 | 122.449 | -13,70 | 131,73 | -2.561.139 | 16.130.488 | |
2015-07-17 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 25.000 | 225.472 | 12,47 | 7,50 | 187.500 | 1.691.040 | |
2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -733 | 1.467 | -33,32 | ||||
2015-07-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 733 | 141.891 | 0,52 | ||||
2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -54.999 | 0 | -100,00 | ||||
2015-06-26 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 54.999 | 480.875 | 12,91 | 3,48 | 191.397 | 1.673.445 | |
2015-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.983 | 9.983 | |||||
2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 1.000 | 1.000 | |||||
2015-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 10.000 | 10.000 | |||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.068 | 0 | -100,00 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.068 | 141.158 | 1,49 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.066 | 2.068 | -49,98 | ||||
2015-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.066 | 139.090 | 1,51 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 129 | -66,67 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.500 | 750 | -66,67 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 35.211 | -9,09 | ||||
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 124.531 | 0,21 | 23,26 | 6.001 | 2.896.591 | |
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.500 | 124.273 | 1,22 | 23,26 | 34.890 | 2.890.590 | |
2015-06-11 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 122.773 | 2,95 | 5,05 | 17.781 | 620.004 | |
2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Employee stock option (right to buy) |
M - Exercise | -25.000 | 54.999 | -31,25 | ||||
2015-06-08 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
M - Exercise | 25.000 | 425.876 | 6,24 | 3,48 | 87.000 | 1.482.048 | |
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8.750 | 11.250 | 350,00 | ||||
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | 8.333 | 14.167 | 142,84 | ||||
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 8.750 | 69.583 | 14,38 | 1,37 | 11.988 | 95.329 | |
2015-06-04 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common STock |
M - Exercise | 8.333 | 60.833 | 15,87 | 0,32 | 2.667 | 19.467 | |
2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Non-Employee Restricted Stock Unit |
M - Exercise | -5.000 | 0 | -100,00 | ||||
2015-05-21 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5.000 | 88.750 | 5,97 | ||||
2015-05-19 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -50.000 | 211.032 | -19,15 | 18,09 | -904.630 | 3.818.118 | |
2015-05-19 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5.000 | 5.000 | |||||
2015-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Deferred Stock Units |
A - Award | 10.650 | 10.650 | |||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -130 | 387 | -25,15 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -750 | 2.250 | -25,00 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.761 | 38.732 | -4,35 | ||||
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 130 | 119.252 | 0,11 | 23,26 | 3.024 | 2.773.802 | |
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 750 | 119.122 | 0,63 | 23,26 | 17.445 | 2.770.778 | |
2015-04-07 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.761 | 118.372 | 1,51 | 5,05 | 8.893 | 597.779 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -258 | 517 | -33,29 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.500 | 3.000 | -33,33 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 40.493 | -8,00 | ||||
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 116.611 | 0,22 | 23,26 | 6.001 | 2.712.372 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.500 | 116.353 | 1,31 | 23,26 | 34.890 | 2.706.371 | |
2015-03-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 114.853 | 3,16 | 5,05 | 17.781 | 580.008 | |
2015-03-06 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 4.000 | 200.472 | 2,04 | 6,57 | 26.280 | 1.317.081 | |
2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Restricted Stock Unit |
A - Award | 6.000 | 6.000 | |||||
2015-02-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.000 | 5.000 | |||||
2015-02-09 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 30.000 | 196.472 | 18,02 | 5,85 | 175.500 | 1.149.361 | |
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7.666 | 0 | -100,00 | ||||
2015-02-04 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7.666 | 137.024 | 5,93 | 27,69 | 212.272 | 3.794.195 | |
2015-01-28 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 44.000 | 44.000 | |||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock (Right to Buy) |
M - Exercise | -258 | 775 | -24,98 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -1.500 | 4.500 | -25,00 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.521 | 44.014 | -7,41 | ||||
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 258 | 111.332 | 0,23 | 23,26 | 6.001 | 2.589.582 | |
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 1.500 | 111.074 | 1,37 | 23,26 | 34.890 | 2.583.581 | |
2015-01-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.521 | 109.574 | 3,32 | 5,05 | 17.781 | 553.349 | |
2015-01-13 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 5.000 | 5.000 | |||||
2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -30.000 | 0 | -100,00 | ||||
2014-12-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 30.000 | 166.472 | 21,98 | 4,25 | 127.500 | 707.506 | |
2014-12-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 261.032 | -3,69 | 12,96 | -129.618 | 3.383.445 |
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 253.846 | 597.232 | 73,92 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 253.846 | 597.232 | 73,92 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series A Warrant to Purchase Common Stock |
P - Purchase | 44.770 | 89.540 | 100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series B Warrant to Purchase Common Stock |
P - Purchase | 44.770 | 89.540 | 100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 21.928 | 43.893 | 99,83 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 8.275 | 21.965 | 60,45 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Warrant to Purchase Common Stock |
J - Other | 13.690 | 13.690 | |||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10.416 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -10.416 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Series C Preferred Stock |
C - Conversion | -48.885 | 20.832 | -70,12 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2014 Convertible Promissory Notes |
S - Sale | -203.705 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -555.250 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -260.471 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
2010/2012 Convertible Promissory Notes |
S - Sale | -471.192 | 0 | -100,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 253.846 | 632.720 | 67,00 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 44.770 | 378.874 | 13,40 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 114.072 | 334.104 | 51,84 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 53.512 | 220.032 | 32,14 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
P - Purchase | 96.803 | 166.520 | 138,85 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10.416 | 69.717 | 17,56 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 10.416 | 69.717 | 17,56 | ||||
2014-11-20 |
|
4 | CAPN |
Capnia, Inc.
Common Stock |
C - Conversion | 48.885 | 48.885 | |||||
2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 7.000 | 56.772 | 14,06 | ||||
2014-11-14 |
|
4 | CAPN |
Capnia, Inc.
Employee Stock Option |
A - Award | 49.772 | 56.772 | 711,03 | ||||
2014-11-12 | 3 | CAPN |
Capnia, Inc.
No securities beneficially owned |
0 | ||||||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 106.053 | 10,41 | 29,00 | 290.000 | 3.075.537 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -517 | 1.033 | -33,35 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -3.000 | 6.000 | -33,33 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -5.282 | 47.535 | -10,00 | ||||
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 517 | 96.053 | 0,54 | 23,26 | 12.025 | 2.234.193 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 3.000 | 95.536 | 3,24 | 23,26 | 69.780 | 2.222.167 | |
2014-11-06 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 5.282 | 92.536 | 6,05 | 5,05 | 26.674 | 467.307 | |
2014-11-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 271.032 | -3,56 | 13,30 | -132.998 | 3.604.671 |
2014-11-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
A - Award | 13.177 | 281.032 | 4,92 | ||||
2014-10-31 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.000 | 5.000 | |||||
2014-10-29 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -100.000 | 129.358 | -43,60 | 102,85 | -10.284.630 | 13.303.992 | |
2014-10-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 267.855 | -3,60 | 12,06 | -120.600 | 3.230.331 |
2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -10.000 | 30.000 | -25,00 | ||||
2014-09-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 10.000 | 136.472 | 7,91 | 4,25 | 42.500 | 580.006 | |
2014-09-08 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 87.254 | 12,94 | 23,19 | 231.872 | 2.023.176 | |
2014-09-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 277.855 | -3,47 | 12,60 | -125.992 | 3.500.751 |
2014-09-03 |
|
4 | Kin |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 10.000 | 52.500 | 23,53 | 10,55 | 105.493 | 553.838 | |
2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
X - Other | -7.059 | 40.000 | -15,00 | ||||
2014-08-27 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
X - Other | 7.059 | 126.472 | 5,91 | 4,25 | 30.001 | 537.506 | |
2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -8.803 | 52.817 | -14,29 | ||||
2014-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 8.803 | 77.254 | 12,86 | 5,05 | 44.455 | 390.133 | |
2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2.500 | 22.500 | -10,00 | ||||
2014-08-06 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2.500 | 42.500 | 6,25 | 0,32 | 800 | 13.600 | |
2014-08-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 287.855 | -3,36 | 12,58 | -125.817 | 3.621.705 |
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -5.000 | 7.666 | -39,48 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 5.000 | 229.358 | 2,23 | 27,69 | 138.450 | 6.350.923 | |
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2.574 | -7,08 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -196 | 2.574 | -7,08 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.210 | 2.770 | -44,38 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -2.210 | 2.770 | -44,38 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1.020 | 4.980 | -17,00 | ||||
2014-07-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
G - Gift | -1.020 | 4.980 | -17,00 | ||||
2014-07-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 297.855 | -3,25 | 12,95 | -129.468 | 3.856.269 |
2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 2.200 | 2.200 | |||||
2014-07-02 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 20.700 | 20.700 | |||||
2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 1.550 | 1.550 | |||||
2014-06-24 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
A - Award | 9.000 | 9.000 | |||||
2014-06-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.000 | 5.000 | |||||
2014-06-17 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5.000 | 5.000 | |||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.055 | 113.892 | 1,84 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -2.055 | 0 | -100,00 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -3.100 | 0 | -100,00 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 3.100 | 111.837 | 2,85 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1.033 | 1.034 | -49,98 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1.033 | 108.737 | 0,96 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1.033 | 2.067 | -33,32 | ||||
2014-06-16 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1.033 | 107.704 | 0,97 | ||||
2014-06-11 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15.000 | 15.000 | |||||
2014-06-03 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 307.855 | -3,15 | 12,88 | -128.790 | 3.964.865 |
2014-05-28 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 10.000 | 68.451 | 17,11 | 14,22 | 142.200 | 973.373 | |
2014-05-27 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 30.000 | 83.750 | 55,81 | 3,73 | 111.978 | 312.605 | |
2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -2.500 | 25.000 | -9,09 | ||||
2014-05-23 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 2.500 | 40.000 | 6,67 | 0,32 | 800 | 12.800 | |
2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee direct stock unit |
M - Exercise | -5.000 | 0 | -100,00 | ||||
2014-05-16 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
M - Exercise | 5.000 | 53.750 | 10,26 | ||||
2014-05-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 317.855 | -3,05 | 12,58 | -125.836 | 3.999.760 |
2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6.000 | 6.333 | -48,65 | ||||
2014-04-08 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6.000 | 106.671 | 5,96 | 55,38 | 332.280 | 5.907.440 | |
2014-04-02 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 327.855 | -2,96 | 13,55 | -135.527 | 4.443.320 |
2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -7.047 | 61.620 | -10,26 | ||||
2014-04-01 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 7.047 | 58.451 | 13,71 | 5,05 | 35.587 | 295.178 | |
2014-03-05 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 337.855 | -2,87 | 12,98 | -129.755 | 4.383.838 |
2014-02-26 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 5.500 | 5.500 | |||||
2014-02-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -17.104 | 347.855 | -4,69 | 12,80 | -218.935 | 4.452.614 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6.875 | 0 | -100,00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4.625 | 0 | -100,00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2.000 | 0 | -100,00 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
S - Sale | -13.500 | 100.671 | -11,82 | 151,87 | -2.050.284 | 15.289.197 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6.875 | 114.171 | 6,41 | 60,02 | 412.638 | 6.852.543 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4.625 | 107.296 | 4,50 | 67,75 | 313.344 | 7.269.304 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.000 | 102.671 | 1,99 | 59,89 | 119.780 | 6.148.966 | |
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -7.000 | 6.875 | -50,45 | ||||
2014-02-06 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 7.000 | 100.671 | 7,47 | 60,02 | 420.140 | 6.042.273 | |
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
M - Exercise | -12.500 | 27.500 | -31,25 | ||||
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
M - Exercise | 12.500 | 37.500 | 50,00 | 0,32 | 4.000 | 12.000 | |
2014-02-05 |
|
4 | KIN |
Kindred Biosciences, Inc.
Stock Option (right to buy) |
A - Award | 37.000 | 37.000 | |||||
2014-02-04 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 364.959 | -2,67 | 13,19 | -131.884 | 4.813.225 |
2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -2.000 | 2.000 | -50,00 | ||||
2014-01-09 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 2.000 | 93.671 | 2,18 | 59,89 | 119.780 | 5.609.956 | |
2014-01-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 374.959 | -2,60 | 12,50 | -125.000 | 4.686.988 |
2013-12-30 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | X | -10.000 | 384.959 | -2,53 | 12,06 | -120.600 | 4.642.606 |
2013-12-13 |
|
4 | KIN |
Kindred Biosciences, Inc.
Common Stock |
P - Purchase | 25.000 | 25.000 | 7,00 | 175.000 | 175.000 | ||
2013-12-13 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 5.000 | 51.404 | 10,77 | 13,90 | 69.500 | 714.516 | |
2013-11-25 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 8.000 | 46.404 | 20,83 | 15,20 | 121.600 | 705.341 | |
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Stock Option (Right to Buy) |
M - Exercise | -15.840 | 68.667 | -18,74 | ||||
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
M - Exercise | 15.840 | 38.404 | 70,20 | 5,05 | 79.992 | 193.940 | |
2013-11-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 7.500 | 22.564 | 49,79 | 15,25 | 114.375 | 344.101 | |
2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -20.445 | 0 | -100,00 | 11,73 | -239.857 | ||
2013-11-12 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
S - Sale | -115.200 | 394.959 | -22,58 | 11,73 | -1.351.503 | 4.633.580 | |
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -6.000 | 4.000 | -60,00 | ||||
2013-10-28 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 6.000 | 91.671 | 7,00 | 59,89 | 359.340 | 5.490.176 | |
2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
M - Exercise | -18.750 | 11.250 | -62,50 | ||||
2013-09-30 |
|
4 | XNPT |
XENOPORT INC
Common stock |
M - Exercise | 18.750 | 48.750 | 62,50 | 5,79 | 108.562 | 282.262 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 64 | 15.064 | 0,43 | 15,75 | 1.008 | 237.258 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 786 | 15.000 | 5,53 | 15,80 | 12.419 | 237.000 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1.714 | 14.214 | 13,71 | 15,80 | 27.081 | 224.581 | |
2013-09-03 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.500 | 12.500 | 25,00 | 15,85 | 39.625 | 198.125 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 10.000 | 25,00 | 16,80 | 33.600 | 168.000 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 8.000 | 33,33 | 17,30 | 34.600 | 138.400 | |
2013-08-27 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 1.960 | 6.000 | 48,51 | 17,50 | 34.300 | 105.000 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 40 | 4.040 | 1,00 | 17,50 | 700 | 70.700 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 4.000 | 100,00 | 17,50 | 35.000 | 70.000 | |
2013-08-20 |
|
4 | CMRX |
CHIMERIX INC
Common Stock |
P - Purchase | 2.000 | 2.000 | 17,45 | 34.900 | 34.900 | ||
2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4.625 | 0 | -100,00 | ||||
2013-08-15 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4.625 | 85.671 | 5,71 | 54,35 | 251.369 | 4.656.219 | |
2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Series A common stock purchase warrant |
P - Purchase | 47.059 | 47.059 | |||||
2013-08-15 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, $0.001 par value |
P - Purchase | 47.059 | 119.713 | 64,77 | ||||
2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -1.033 | 2.067 | -33,32 | ||||
2013-06-17 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 1.033 | 81.046 | 1,29 | ||||
2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3.100 | 3.100 | |||||
2013-06-14 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9.300 | 9.300 | |||||
2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -15.000 | 10.000 | -60,00 | ||||
2013-06-07 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 15.000 | 80.013 | 23,07 | 59,89 | 898.350 | 4.791.979 | |
2013-05-30 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15.000 | 81.125 | 22,68 | 14,68 | 220.206 | 1.190.947 | |
2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 400 | 65.013 | 0,62 | 123,73 | 49.493 | 8.044.189 | |
2013-05-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
P - Purchase | 600 | 64.613 | 0,94 | 123,72 | 74.232 | 7.993.920 | |
2013-05-23 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 20.000 | 30.000 | 200,00 | 5,49 | 109.800 | 164.700 | |
2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock unit |
A - Award | 5.000 | 5.000 | |||||
2013-05-16 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 15.000 | 15.000 | |||||
2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 22.756 | 130.098 | 21,20 | ||||
2013-05-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 30.000 | 509.304 | 6,26 | 7,76 | 232.800 | 3.952.199 | |
2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Warrants |
C - Conversion | -166.667 | 216.667 | -43,48 | ||||
2013-04-29 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock |
C - Conversion | 166.667 | 1.447.079 | 13,02 | 0,40 | 66.667 | 578.832 | |
2013-02-19 |
|
4 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Stock Option |
A - Award | 210.000 | 0 | -100,00 | ||||
2013-01-29 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 21.125 | 66.125 | 46,94 | ||||
2013-01-14 | 3 | TNXP |
Tonix Pharmaceuticals Holding Corp.
Common Stock, Par Value $0.001 |
1.280.412 | ||||||||
2012-08-21 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5.000 | 45.000 | 12,50 | 20,75 | 103.750 | 933.750 | |
2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 5.000 | 40.000 | 14,29 | 21,50 | 107.500 | 860.000 | |
2012-08-13 |
|
4 | VVUS |
VIVUS INC
Common Stock |
P - Purchase | 15.000 | 35.000 | 75,00 | 21,83 | 327.399 | 763.931 | |
2012-08-09 |
|
4 | XNPT |
XENOPORT INC
Common Stock |
P - Purchase | 10.000 | 10.000 | 8,50 | 84.983 | 84.983 | ||
2012-08-08 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 32.000 | 479.304 | 7,15 | 5,29 | 169.280 | 2.535.518 | |
2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
M - Exercise | -685 | 0 | -100,00 | ||||
2012-06-19 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 685 | 64.013 | 1,08 | ||||
2012-06-18 |
|
4 | XNPT |
XENOPORT INC
Non-employee director stock option |
A - Award | 30.000 | 30.000 | |||||
2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Restricted Stock Unit |
A - Award | 3.100 | 3.100 | |||||
2012-06-15 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
A - Award | 9.300 | 9.300 | |||||
2012-06-07 |
|
4 | MAXY |
MAXYGEN INC
Common Stock |
A - Award | 10.000 | 62.964 | 18,88 | ||||
2012-05-10 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 24.116 | 107.342 | 28,98 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -12.333 | 0 | -100,00 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Stock Option (right to buy) |
M - Exercise | -4.625 | 0 | -100,00 | ||||
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 12.333 | 63.328 | 24,18 | 44,94 | 554.245 | 2.845.960 | |
2012-04-30 |
|
4 | CELG |
CELGENE CORP /DE/
Common Stock |
M - Exercise | 4.625 | 50.995 | 9,97 | 49,93 | 230.926 | 2.546.180 | |
2012-04-27 |
|
4 | VVUS |
VIVUS INC
Common Stock |
A - Award | 20.000 | 20.000 | |||||
2012-02-27 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10.000 | 447.304 | 2,29 | 5,91 | 59.100 | 2.643.567 | |
2012-02-23 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 10.000 | 437.304 | 2,34 | 5,93 | 59.300 | 2.593.213 | |
2012-02-22 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 20.000 | 427.304 | 4,91 | 6,12 | 122.400 | 2.615.100 | |
2011-02-09 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Common Stock |
P - Purchase | 50.000 | 131.004 | 61,73 | 6,94 | 346.990 | 909.142 | |
2009-05-07 |
|
4 | BSX |
BOSTON SCIENTIFIC CORP
Phantom Stock |
A - Award | 14.501 | 42.521 | 51,75 | ||||
2007-08-23 | 3 | CELG |
CELGENE CORP /DE/
Common Stock |
10.000 |